Sanovel İlaç
Leyla Karadeniz is a seasoned professional in the pharmaceutical industry with extensive experience in portfolio strategy, business development, and regulatory affairs. Currently serving as the Portfolio Strategy & Licensing Manager at Sanovel İlaç since May 2023, Leyla previously held leadership roles at Exeltis Turkey, first as Head of Business Development & Portfolio from March 2020 to May 2023 and earlier as Business Development & Portfolio Manager. Leyla's career commenced at İlko İlaç San. ve Tic. A.Ş., where contributions spanned multiple positions from December 2012 to February 2020, including Business Development Executive and Regulatory Affairs Specialist. Prior experience includes a role at Neutec Grup as a Regulatory Affairs Researcher. Leyla holds a Bachelor of Science in Chemical Engineering from Yeditepe University, complemented by an exchange program at the Rose-Hulman Institute of Technology in 2008.
This person is not in any offices
Sanovel İlaç
Sanovel, which produces at world standards without making any concessions to its principles and quality, was founded by Pharmacist Erol Toksöz. Having set up Ankara Galenos Pharmaceutical Warehouse in 1971, which is a step into the pharmaceutical industry, he purchased Adilna in 1982. He established Sanovel in 1983. Having started its production in Şişli, Sanovel today brings Turkish pharmaceutical industry to the future at modern facilities with an indoor space of 53,000 m2, located on an area of 125,000 m2. Having made a quick and stable improvement since its foundation, Sanovel is one of the leading companies in the pharmaceutical industry. Sanovel Pharmaceutical’s production facility, first laid foundation at İstanbul Silivri Çantaköy in 2001, fully started production as of November 2006. The production site comprises the main production unit, cephalosporin production unit, refining unit, elevated storage and social recreational facility. The production capacity is 227 million units per year. Closely following the developments in the world, Sanovel sets an example for the whole Turkish pharmaceutical industry, with the huge investments it makes in human resources and Research & Development studies.